HeartSciences Inc

NASDAQ:HSCSUnited States

HeartSciences Inc. is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The Company has libraries of artificial intelligence-enhanced electrocardiography (AI-ECG) algorithms and is developing AI-ECG solutions to be made available on either a hardware- agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction, which has traditionally only been available through the use of cardiac imaging. The MyoVista also provides conventional ECG information in the same test. It delivers AI-ECG algorithms using existing ECG devices across a hospital or health system.

Contact Information

Headquarters

550 Reserve St, Suite 360SOUTHLAKE, TX, United States 76092

Phone

682-237-7781

Fax

---

Executives

Chairman of the Board, President, Chief Executive Officer

Andrew Simpson

Chief Financial Officer, Treasurer

Danielle Watson

Chief Operating Officer, Secretary, Director

Mark Hilz

Independent Director

Bruce Bent

Independent Director

Brian Szymczak